Receive Our Newsletter

Bloomberg News: Merck Data a Potent Rival to Gilead’s Hepatitis C Pill

By: Drew Armstrong Merck & Co. (MRK)’s experimental hepatitis C pill produced clinical trial results positioning the drug as a strong competitor to a potential blockbuster therapy from Gilead Sciences Inc. (GILD) Merck’s two-drug combination once-a-day pill stopped the virus in 98 percent of newly treated patients with few major side effects, according to a […]

3714_RyanWhiteRayBros

1980’s: Hemophilia, HIV/AIDS, and Hepatitis C

In 1982, the Centers for Disease Control (CDC) reported the first case of HIV/AIDS among people with #hemophilia, and concerns began to grow that the blood supply was tainted. Despite warnings from the CDC, leaders in the hemophilia community encouraged patients to continue using clotting factor (more information below). In 1983, several manufacturers began the […]

NY Times: Progress Against Hepatitis C, a Sneaky Virus

Forty years ago, a beloved neighbor was bedridden for weeks at a time with a mysterious ailment. She knew only that it involved her liver and that she must never drink alcohol, which would make things worse. It was decades before the cause of these debilitating flare-ups was discovered: a viral infection at first called […]

HCV

Hepatitis C: Our History and Advances on the Horizon

Recognizing National Hepatitis Awareness Month The month of May is recognized to bring awareness around those living with viral hepatitis. The awareness effort encourages people to get tested for hepatitis and to evaluate treatment options. According to the Centers for Disease Control and Prevention (CDC), an estimated 3.2 million people in the U.S. with chronic […]

White House Petition: Help Save Lives of Millions With Hepatitis C

Dear Friends, We need your help in order to get this cure for Hepatitis C. · Over 170 million people worldwide have Hepatitis C (HCV) · Hepatitis C now kills more people than AIDS · Hepatitis C is now the leading reason for liver transplants The cure was developed by two drug companies together, but […]

Gilead Sciences Petition: Stop Withholding This Cure for Hepatitis C

TO: Supporters and Friends of People with Bleeding Disorders and HCV: Previously we described the situation in which Gilead Sciences, a drug development firm, likely found a cure …. and walked away from it, solely for the business reasons.  Explanation: they own only half of the successful drug combination and they don’t want to split […]

HFA Observes National Hepatitis Awareness Month

HFA Observes National Hepatitis Awareness Month FOR IMMEDIATE RELEASE: May 3, 2012 Contact: Richard Pezzillo (202)-675-6984 r.pezzillo@hemophiliafed.org Link to PDF of HFA Celebrates Hepatitis Awareness Month Washington, D.C. – In 2001, the Centers for Disease Control (CDC) and Prevention designated the month of May as Hepatitis Awareness Month to bring awareness and attention to those living with viral […]

Living With Hepatitis C

Mark Antell talks candidly about his hemophilia and hepatitis C.

Viral Outbreaks in Dogs Yield Clues on Origins of Hepatitis C

New York Times article link By CARL ZIMMER Published: May 30, 2011 Hepatitis C is, in some ways, a high-profile disease. Worldwide, an estimated 200 million people are infected with the virus. Some of them will suffer cirrhosis, liver cancer and even death. Celebrities like Steven Tyler of Aerosmith and “American Idol” have spoken publicly […]

Merck’s Hepatitis C Drug Wins F.D.A. Approval

Click here for New York Times article. By ANDREW POLLACK Published: May 13, 2011 The Food and Drug Administration approved on Friday the first of a new generation of hepatitis C drugs that promises to increase the cure rate while shortening the time required for treatment. The new drug, Victrelis from Merck, effectively cured more […]

Page 2 of 3123

Assisting and Advocating for the Bleeding Disorders Community